Compositions and methods for the treatment of altered alpha-synuclein function

Details for Australian Patent Application No. 2009314447 (hide)

Owner Parkinson's Institute The Hospital for Sick Children Neuraltus Pharmaceuticals, Inc.

Inventors Manning-Bog, Amy B.; Shule, Birgitt; Langston, J. William; Lingwood, Cliff A.; McGrath, Michael S.; Azhir, Arasteh Ari

Agent Pizzeys

Pub. Number AU-A-2009314447

PCT Pub. Number WO2010/056413

Priority 61/199,243 14.11.08 US

Filing date 4 September 2009

Wipo publication date 20 May 2010

International Classifications

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/056413 Priority application(s): WO2010/056413

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314449-Systems and methods for dynamically developing wellbore plans with a reservoir simulator

2009314446-Process and system for the addition of promoter metal in situ in a catalytic reforming unit